<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Initial treatment of locoregional, nonmetastatic HPV associated oropharyngeal squamous cell carcinoma of the head and neck</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Initial treatment of locoregional, nonmetastatic HPV associated oropharyngeal squamous cell carcinoma of the head and neck</h1>
<div class="graphic"><div class="figure"><div class="ttl">Initial treatment of locoregional, nonmetastatic HPV associated oropharyngeal squamous cell carcinoma of the head and neck</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">The treatment of HPV associated OPSCC involves various treatment modalities, either as single agents or in combination including surgery, RT, and chemotherapy. Treatment for patients with HPV associated oropharyngeal cancer is the same as for those with non-HPV associated oropharyngeal cancers, except in the context of a clinical trial, including deintensification regimens.</div><div class="graphic_footnotes"><p>HPV: human papillomavirus; TNM: tumor, node, metastasis; RT: radiation therapy; OPSCC: oropharyngeal squamous cell carcinoma; PNI: perineural invasion; LVI: lymphovascular invasion.</p>
<p>* Adjuvant RT with or without concurrent chemotherapy may be indicated for tumors with high-risk findings on postoperative pathology. Adjuvant RT may be offered to those with one node &gt;3 cm, close margins, PNI, or LVI. Adjuvant chemoradiation may be offered to those whose pathology demonstrates extranodal extension with or without positive margins, high number of involved lymph nodes, or positive margins not eligible for further resection.</p>
<p>¶ Single agent RT may be indicated for nonsmoking patients with one small single node without adverse features on clinical evaluation or high quality imaging (eg, ≤3 cm, no radiographic evidence of extranodal extension).</p>
Δ Definitive chemoradiation may be indicated in patients who are active or heavy smokers, or who have one involved node with certain high-risk features suspicious for a more advanced primary tumor or advanced nodal disease on clinical evaluation or radiographic imaging. Examples of such high-risk features include endophytic, ulcerated primary tumors; radiographic evidence of extranodal extension or nodal matting; highly suspicious clustered or small lymph nodes; or involvement of retropharyngeal, level IV, or level V lymph nodes.</div><div id="graphicVersion">Graphic 129299 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
